Related Experiment Video
Updated: Jun 4, 2026
06:49
Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent
Karunakar Kar1, Murali Jayaraman, Bankanidhi Sahoo
1Structural Biology Department, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Nature Structural & Molecular Biology
|February 15, 2011
Summary
Polyglutamine (polyQ) aggregation in neurodegenerative diseases depends on nucleus size. Shorter polyQ repeats (Q23-Q26) show increasing nucleus sizes, suggesting a role in disease progression.
Area of Science:
- Biophysics
- Molecular Biology
- Neuroscience
Background:
- Polyglutamine (polyQ) aggregate formation is central to expanded CAG repeat diseases.
- Understanding the biophysics of initial aggregation is crucial for these diseases.
Purpose of the Study:
- To investigate how the size of the critical nucleus for polyQ aggregation changes with repeat length.
- To explore the structural basis and implications of nucleus size variation in polyQ aggregation.
Main Methods:
- Studied polyglutamine peptides with repeat lengths from Q(23) to Q(26).
- Analyzed the size of the critical nucleus required for aggregation initiation.
Main Results:
- Observed an increase in critical nucleus size from monomeric to tetrameric as repeat length increased from Q(23) to Q(26).
- This variation suggests a common antiparallel β-sheet duplex framework for aggregation nuclei.
- Findings support the feasibility of organized monomeric aggregation nuclei for longer polyQ peptides.
Conclusions:
- The size of polyQ aggregation nuclei can vary with repeat length.
- Changes in nucleus size may contribute to the pathogenicity of polyQ expansion in familial neurodegenerative diseases.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...